JENNA GUTIERREZ: Open Payments
NPI 1134734635 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 11 payments from 5 companies in 2025. Trend: 2023 $1,359 · 2024 $1,118 · 2025 $341
Food & beverage: $341
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 4 | $118 |
| Lilly USA, LLC | 4 | $110 |
| Otsuka America Pharmaceutical, Inc. | 1 | $60 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $35 |
| ABBVIE INC. | 1 | $18 |
Products named: Leqembi, KISUNLA, REXULTI, LINZESS.
Industry payments across CA — which companies pay providers there.
